Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Isosorbide mononitrate did not improve activity level, exercise capacity or quality of life of ...
According to a study presented at the American Heart Association’s Scientific Sessions 2015, patients with heart failure with preserved ejection fraction (HFpEF) did not have increased exercise ...
Cilostazol and isosorbide mononitrate, two widely available drugs that have beneficial effects on endothelial function, appear to improve functional and cognitive outcomes when used in patients who ...
Heart failure patients with preserved ejection fraction (HFpEF) -- where the heart becomes stiff and cannot relax or fill properly -- did not have increased exercise tolerance after taking isosorbide ...
Eight healthy male volunteers aged 19–31 years who were non-smokers with no history of hypertension and no contraindications to cortisol administration were recruited for this study. Subjects were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results